OXYMETAZOLINE HCL

N/A

Manufactured by Wal-Mart Stores Inc

1,077 FDA adverse event reports analyzed

Last updated: 2026-04-15

About OXYMETAZOLINE HCL

OXYMETAZOLINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Wal-Mart Stores Inc. The most commonly reported adverse reactions for OXYMETAZOLINE HCL include DRUG INEFFECTIVE, ANOSMIA, DYSPNOEA, FATIGUE, DIZZINESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for OXYMETAZOLINE HCL.

Top Adverse Reactions

DRUG INEFFECTIVE39 reports
ANOSMIA30 reports
DYSPNOEA28 reports
FATIGUE26 reports
DIZZINESS25 reports
HEADACHE25 reports
AGEUSIA24 reports
NAUSEA23 reports
DIARRHOEA22 reports
ANXIETY20 reports
PNEUMONIA20 reports
VOMITING20 reports
FALL19 reports
PAIN19 reports
PRODUCT USE ISSUE19 reports
ARTHRALGIA18 reports
CONSTIPATION16 reports
COUGH16 reports
WEIGHT DECREASED16 reports
ABDOMINAL PAIN UPPER15 reports
ASTHENIA15 reports
PYREXIA15 reports
RASH15 reports
FEELING ABNORMAL13 reports
INSOMNIA13 reports
NASAL CONGESTION13 reports
PRURITUS13 reports
RENAL FAILURE13 reports
OFF LABEL USE12 reports
PAIN IN EXTREMITY12 reports
CHRONIC KIDNEY DISEASE11 reports
DEPRESSION11 reports
HYPERSENSITIVITY11 reports
HYPOTENSION11 reports
ABDOMINAL DISCOMFORT10 reports
ACUTE KIDNEY INJURY10 reports
BACK PAIN10 reports
DECREASED APPETITE10 reports
HYPERTENSION10 reports
INCORRECT DOSE ADMINISTERED10 reports
NASAL DISCOMFORT10 reports
WEIGHT INCREASED10 reports
INJURY9 reports
MALAISE9 reports
MUSCLE SPASMS9 reports
NASOPHARYNGITIS9 reports
PHARMACEUTICAL PRODUCT COMPLAINT9 reports
PRODUCT DOSE OMISSION ISSUE9 reports
ABDOMINAL PAIN8 reports
BLOOD PRESSURE INCREASED8 reports
DRUG DOSE OMISSION8 reports
EPISTAXIS8 reports
EYE IRRITATION8 reports
GASTROOESOPHAGEAL REFLUX DISEASE8 reports
HALLUCINATION8 reports
INFLUENZA8 reports
MYOCARDIAL INFARCTION8 reports
BURNING SENSATION7 reports
CHEST PAIN7 reports
CONFUSIONAL STATE7 reports
DYSGEUSIA7 reports
INCORRECT DRUG ADMINISTRATION DURATION7 reports
LACRIMATION INCREASED7 reports
OVERDOSE7 reports
SOMNOLENCE7 reports
SWELLING7 reports
TREMOR7 reports
ABDOMINAL DISTENSION6 reports
ATRIAL FIBRILLATION6 reports
BLOOD CHOLESTEROL INCREASED6 reports
DRUG HYPERSENSITIVITY6 reports
DYSPHAGIA6 reports
GAIT DISTURBANCE6 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION6 reports
INFECTION6 reports
LOSS OF CONSCIOUSNESS6 reports
OEDEMA PERIPHERAL6 reports
PLEURAL EFFUSION6 reports
PNEUMONIA ASPIRATION6 reports
PRODUCT QUALITY ISSUE6 reports
PULMONARY EMBOLISM6 reports
SINUS DISORDER6 reports
SINUSITIS6 reports
VISION BLURRED6 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS6 reports
AGITATION5 reports
ALANINE AMINOTRANSFERASE INCREASED5 reports
ALOPECIA5 reports
ANAEMIA5 reports
ARTHRITIS5 reports
ASPARTATE AMINOTRANSFERASE INCREASED5 reports
BLOOD GLUCOSE INCREASED5 reports
BODY HEIGHT DECREASED5 reports
BRONCHITIS5 reports
CEREBROVASCULAR ACCIDENT5 reports
CHILLS5 reports
CORONARY ARTERY DISEASE5 reports
COVID 195 reports
DEHYDRATION5 reports
DRY MOUTH5 reports

Report Outcomes

Out of 525 classified reports for OXYMETAZOLINE HCL:

Serious 54.7%Non-Serious 45.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female315 (63.0%)
Male181 (36.2%)
Unknown4 (0.8%)

Reports by Age

Age 5814 reports
Age 5712 reports
Age 5411 reports
Age 2710 reports
Age 7110 reports
Age 709 reports
Age 729 reports
Age 408 reports
Age 628 reports
Age 658 reports
Age 758 reports
Age 768 reports
Age 477 reports
Age 537 reports
Age 617 reports
Age 697 reports
Age 817 reports
Age 837 reports
Age 376 reports
Age 426 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with OXYMETAZOLINE HCL?

This profile reflects 1,077 FDA FAERS reports that mention OXYMETAZOLINE HCL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for OXYMETAZOLINE HCL?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, ANOSMIA, DYSPNOEA, FATIGUE, DIZZINESS, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures OXYMETAZOLINE HCL?

Labeling and FAERS entries often list Wal-Mart Stores Inc in connection with OXYMETAZOLINE HCL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.